A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
This study has been completed.
First Posted: November 18, 2010
Last Update Posted: September 16, 2016
Information provided by (Responsible Party):